FIELD: medicine; pharmaceuticals.
SUBSTANCE: invention relates to a compound of formula (I), or a pharmaceutically acceptable salt thereof:
.
Value of radicals R1, R2, R3, R5, R7, R8, X1, X2 and n is defined in the claim. What is also presented is a pharmaceutical composition, a method of treating or preventing a disease involving overexpression of SUV39H2, and use of the compound of formula (I) for preparing the drug.
EFFECT: disclosed compound has inhibitory activity on SUV39H2 and can be used for treating a malignant tumor.
18 cl, 13 tbl
Title | Year | Author | Number |
---|---|---|---|
PYRIDONE DERIVATIVE HAVING TETRAHYDROPYRANYLMETHYL GROUP | 2015 |
|
RU2707953C2 |
CHEMICAL COMPOUNDS 637: PYRIDOPYRIMIDINEDIONES AS PDE4 INHIBITORS | 2008 |
|
RU2479584C2 |
IMIDAZOPYRIDIN-2-ONE DERIVATIVES, HAVING mTOR INHIBITING ACTIVITY | 2009 |
|
RU2478636C2 |
PYRAZOLE DERIVATIVE SUITABLE AS PI3K INHIBITOR | 2016 |
|
RU2710549C2 |
BICYCLIC NITROIMIDAZOLES COVALENTLY CONNECTED TO REPLACED PHENYLOXAZOLYDINONES | 2009 |
|
RU2504547C2 |
FGFR4 INHIBITORS | 2014 |
|
RU2715708C2 |
QUINOLINE DERIVATIVES AND MELK INHIBITORS CONTAINING SAME | 2011 |
|
RU2582610C2 |
2-AMINOTHIAZOLE DERIVATIVE OR SALT THEREOF | 2015 |
|
RU2702106C2 |
BENZOXAZEPINE PI3K INHIBITORS AND METHODS OF USE | 2010 |
|
RU2600927C2 |
BENZOXAZEPINE PI3 INHIBITORS AND METHODS OF USE | 2010 |
|
RU2654068C1 |
Authors
Dates
2020-08-05—Published
2016-09-12—Filed